What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome.
antibiotic treatment
autoimmune response
borrelia burgdorferi
chronic lyme disease
inflammation
lyme
persistent infection
post-treatment lyme disease
tick-borne
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
accepted:
20
07
2024
medline:
20
8
2024
pubmed:
20
8
2024
entrez:
20
8
2024
Statut:
epublish
Résumé
Post-treatment Lyme disease syndrome (PTLDS), which may also be referred to incorrectly as "chronic Lyme disease," is defined by the Infectious Diseases Society of America (IDSA) as the presence of fatigue, pain, and/or cognitive complaints with the functional impact that persists for more than six months after completing treatment for Lyme disease (LD). These symptoms occur in 10%-20% of patients previously diagnosed with LD caused by the bacteria
Identifiants
pubmed: 39161484
doi: 10.7759/cureus.64987
pmc: PMC11332314
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e64987Informations de copyright
Copyright © 2024, Wester et al.
Déclaration de conflit d'intérêts
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.